Podgor M J, Cassel G H, Kannel W B
N Engl J Med. 1985 Dec 5;313(23):1438-44. doi: 10.1056/NEJM198512053132303.
The Framingham Heart Study was begun in 1948 to study factors associated with cardiovascular disease. Participants have been reexamined approximately every two years. From 1973 to 1975, the Framingham Eye Study examined the eyes of available Heart Study participants. We used information about nearly 2000 persons from these population-based studies to investigate the relation of lens changes to survival. Follow-up ranged from five to eight years; 312 persons (16 per cent) died. Proportional-hazards regression analyses indicated an overall association of lens changes and decreased survival (P = 0.01), but detailed investigation showed (1) no association of lens changes and decreased survival among persons without diabetes (P = 0.29) and (2) a significant association of lens changes and decreased survival among persons with diabetes (P = 0.001). Diabetic persons with lens changes had an estimated death rate more than twice that of diabetics without lens changes. The duration of diabetes and degree of retinopathy were not associated with survival in this group, most of whom had adult-onset diabetes of short duration. We conclude that lens changes are earlier predictors of death in diabetics than these more traditional variables.
弗明汉心脏研究始于1948年,旨在研究与心血管疾病相关的因素。参与者大约每两年接受一次重新检查。1973年至1975年,弗明汉眼科研究对参与心脏研究的人员进行了眼部检查。我们利用这些基于人群的研究中近2000人的信息,来调查晶状体变化与生存率之间的关系。随访时间为5至8年;312人(16%)死亡。比例风险回归分析表明晶状体变化与生存率降低总体相关(P = 0.01),但详细调查显示:(1)在无糖尿病患者中,晶状体变化与生存率降低无关联(P = 0.29);(2)在糖尿病患者中,晶状体变化与生存率降低存在显著关联(P = 0.001)。有晶状体变化的糖尿病患者的估计死亡率是无晶状体变化的糖尿病患者的两倍多。糖尿病病程和视网膜病变程度与该组患者的生存率无关,该组大多数患者为成年起病且病程较短的糖尿病。我们得出结论,与这些更传统的变量相比,晶状体变化是糖尿病患者死亡的早期预测指标。